Clinical Study Agreement Template for England and Wales

A Clinical Study Agreement is a comprehensive legal contract that governs the relationship between all parties involved in clinical research projects. You'll need this document to establish clear roles, responsibilities, and obligations when conducting clinical trials in England and Wales, ensuring compliance with stringent UK regulatory requirements while protecting the interests of sponsors, institutions, and research participants.

When do you need this document?

You'll require a Clinical Study Agreement whenever you're planning to conduct clinical research involving human participants in England and Wales. This includes pharmaceutical trials for new drug development, medical device studies, post-marketing surveillance studies, and investigator-initiated research projects. The agreement is particularly crucial when multiple parties are involved, such as pharmaceutical companies sponsoring trials at NHS trusts or universities, or when Contract Research Organizations are managing studies on behalf of sponsors. You'll also need this document when conducting international multi-site trials that include UK research centers, ensuring that the UK components comply with local regulatory requirements while maintaining consistency with global study protocols.

Key legal considerations

Your Clinical Study Agreement must address several critical legal aspects to ensure robust protection and compliance. Protocol compliance clauses should reference adherence to Good Clinical Practice guidelines and approved study protocols, with clear procedures for protocol amendments and deviations. Data protection provisions must be comprehensive, covering participant confidentiality, data transfer mechanisms, and compliance with UK GDPR requirements. Intellectual property clauses should define ownership of study data, publication rights, and any inventions or discoveries arising from the research. Financial terms need careful structuring to cover study costs, payment schedules, and liability for additional expenses. Safety reporting obligations must align with MHRA requirements and specify timelines for adverse event reporting. Indemnity and insurance provisions should protect all parties from potential claims while ensuring adequate coverage for participant compensation.

Legal requirements in England and Wales

Your Clinical Study Agreement must comply with the Medicines for Human Use (Clinical Trials) Regulations 2004 and the updated UK Clinical Trials Regulations implemented post-Brexit. These regulations mandate specific authorization procedures, safety reporting requirements, and Good Clinical Practice compliance standards. The agreement must incorporate Data Protection Act 2018 and UK GDPR requirements for handling participant personal data, including lawful bases for processing, data subject rights, and international data transfer safeguards. Human Medicines Regulations 2012 may apply if your study involves medicinal products, requiring compliance with manufacturing, distribution, and labeling standards. NHS research governance frameworks must be observed when conducting studies within NHS institutions, including additional ethical approval requirements and clinical negligence considerations. The agreement should also address regulatory inspection rights and specify procedures for maintaining compliance with MHRA oversight and potential regulatory audits.